Please use the "Account creation" link in the top menu to create an account as Corresponding Author; all further correspondence will then be mailed to the address you will specify within the account creation form. A message confirming the creation of the account will be sent to you. Please click on the link received by e-mail to activate your submission account, then you will be allowed to login.

Please remember that:

  1. Having an account to the abstracts submission system DOES NOT MEAN to be registered as a participant to the Workshop;
  2. The Presenting Author of an accepted abstract must be also registered to the Workshop;
  3. Authors are requested to paste the text of each abstract into the dedicated form but can also (after having saved the form) upload their Word/PDF manuscript, as well.
    In addition, a figure or a table can be attached to the abstract previously saved. For any issues, please contact support@abstracts.it;
  4. Abstracts should be self-explanatory without reference to the text. It should include a structured text with the following sections: Introduction/Background, Materials (or Patients) and Methods, Results, Conclusion.
  5. A maximum of 2500 characters (spaces included) is allowed for each abstract text, excluding title, authors and affiliations.
  6. To withdraw an abstract, please send an e-mail to imw2015@thetriumph.com;
  7. After abstract acceptance, each Corresponding Author will receive a letter of notification with all the information about poster size and location.

Rising Star Awards

  1. Four awards of Euro 5.000,00 each will be given to the best abstracts prepared by a under 35 year old first author (physicians only). Winners will have the opportunity to present their work in the plenary session during the meeting.


  1. THE SUBMISSION OF THE ABSTRACTS HAS BEEN CLOSED. The authors area is still available but in read only mode.
  2. Abstract acceptance after June 30, 2015 before July 15, 2015


  1. 1. Multiple Myeloma Genomics, Diagnosis, Prognosis, Imaging;
  2. 2. Multiple Myeloma Therapy in Newly Diagnosed Patients including Transplantation;
  3. 3. Epidemiology, QoL, Toxicities and Other Plasma Cell Dyscrasias;
  4. 4. Multiple Myeloma Biology, Pathophysiology, Preclinical Studies, Bone Disease;
  5. 5. Multiple Myeloma Therapy in Newly Diagnosed Patients excluding Transplantation;
  6. 6. Multiple Myeloma Therapy Relapsed/Refractory Patients;
  7. 7. Nurse Session.

Abstracts will be published in a e-book supplement of Elsevier "Clinical Lymphoma, Myeloma and Leukemia" review.

Editorial contacts:
David Allen
Publisher - STM Journals
Elsevier, Inc.
Phone/Cell: (469) 563-4413